Occurrence and risk assessment of pharmaceuticals and personal care products (PPCPs) against COVID-19 in lakes and WWTP-river-estuary system in Wuhan, China호수에서 Covid-19에 대한 제약 및 개인 의료 제품 (PPCP)의 발생 및 위험 평가 및 중국 우한에있는 WWTP-River-Estuary 시스템Article Published on 2021-10-202022-08-31 Journal: The Science of the total environment [Category] MERS, SARS, 치료기술, 치료제, [키워드] Antibiotics antiviral drugs approach Azithromycin Care category city comparable Concentration Consumption Contamination COVID-19 COVID-19 pandemic declined distribution drug dry weight ecological emergency response evaluate evaluated FIVE Frequency hospital impacts media Occurrence organism pandemic personal care plants potential risk PPCPs Region ribavirin risk Risk assessment river season Space sulfamethoxazole summer Treatment wastewater Wastewater treatment plants. water Wuhan Wuhan, China Yangtze [DOI] 10.1016/j.scitotenv.2021.148352 PMC 바로가기 [Article Type] Article
Histopathological changes in Oreochromis mossambicus (Peters, 1852) ovaries after a chronic exposure to a mixture of the HIV drug nevirapine and the antibiotics sulfamethoxazole and trimethoprimHIV 약물 네비 라핀의 혼합물 및 항생제 설파 메톡 사졸 및 트리 메토 프림의 혼합물에 만성 노출 된 후 오레오 크로 미스 Mossambicus (Peters, 1852) 난소의 조직 병리학 적 변화Article Published on 2021-07-012022-08-31 Journal: Chemosphere [Category] MERS, SARS, 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition adverse effect adverse effects African AIDS antibiotic Antibiotics antiretroviral Antiretrovirals Antiviral aquatic environment ARV atresia Bacterial Biomarkers changes in Compound consequence continent coronavirus drug drugs Effect Endpoint epidemic diseases female fish Fish gonads histopathological Histopathology HIV HIV antiretrovirals HIV drug HIV/AIDS Human immunodeficiency virus immunodeficiency immunodeficiency virus incidence Infection Infectious disease Infectious diseases information interstitial tissue investigated nevirapine Oocyte outbreak pandemic pharmaceutical Pharmaceutical mixtures. recorded respiratory significant difference significant differences sulfamethoxazole Surface waters syndrome triggered trimethoprim Tuberculosis vacuolation Viral water [DOI] 10.1016/j.chemosphere.2021.129900 PMC 바로가기 [Article Type] Article
Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report소아 코로나19 환자에서 발생한 항MDA5 소아 피부근염의 치명적 결과: 증례 보고Case Reports Published on 2021-01-012022-09-11 Journal: Modern rheumatology case reports [Category] 진단, 치료제, [키워드] addition Admission Anti-MDA5 BAL BAS Bronchoalveolar lavage Case report children COVID-19 Cyclophosphamide dermatomyositis diagnosed died disease drug emphysema health condition hemophagocytic lymphohistiocytosis high mortality rate high risk hospital hypoxemic Hypoxemic respiratory failure Immunoglobulin immunosuppressive immunosuppressive therapy Infection initiated Intensive Interstitial lung disease interstitial lung disease (ILD) intravenous Intravenous immunoglobulin juvenile dermatomyositis Lung disease MDA5 Methylprednisolone outcome Patient performed Pneumomediastinum Pneumothorax poor prognosis positive Real-time PCR real-time RT-PCR referred to Respiratory failure risk risk for disease SARS-CoV-2 SARS-COV-2 infection secondary hemophagocytic lymphohistiocytosis Septic shock severe complications subcutaneous emphysema sulfamethoxazole therapy Tofacitinib tofacitinib. Treatment worsening [DOI] 10.1080/24725625.2020.1832755 PMC 바로가기 [Article Type] Case Reports